MedPath

A study of neural mechanism of non-invasive brain stimulation combined rehabilitation training.

Not Applicable
Recruiting
Conditions
eurological diseases
neurological disorders
23.888.592
Registration Number
JPRN-jRCTs012200016
Lead Sponsor
Mukaino Masahiko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
400
Inclusion Criteria

Patients with neurological disorders
1. Nervous disease patients who have the following target diseases and whose diagnosis is established by neurological findings, image findings, etc.
target diseases:
Cerebrovascular disease (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage etc.)
Neurodegenerative diseases (Parkinson's disease ,
Spinocerebellar degeneration etc.)
Neuroinflammatory disease (Multiple sclerosis etc.)
2. Patients who are suffering from any disorder due to neurological disorder, movement disorder, higher brain dysfunction, speech disorder, swallowing disorder.
3. Patients who received sufficient explanation to participate in this study and obtained document consent by the person's free will with sufficient understanding
4. Patients with movement disorders, higher brain dysfunction, speech disorders, or dysphagia due to neurological disorders
5. Patients who have received sufficient explanation before participating in this study, and who have obtained sufficient understanding and consent to the document at their own free will. Or, if it is difficult for the patient to consent to the document, the patient with the document consent obtained by the substitute

Healthy people
1. Those who are 20-90 years old at the time of obtaining consent
2. Those who have no history of neuropsychiatric illness in their declaration.
3. Persons who have received sufficient explanation before participating in this study, and who have obtained sufficient understanding and consent to the document at their own free will.

Exclusion Criteria

Patients with neurological disorders
1. Within 5 days after onset or within 5 days after symptom recurrence
2. Those who have significant hearing impairment and cannot communicate
3. Those who have a cardiac pacemaker
4. Those who are holding a body-metal that cannot be confirmed to be a non-magnetic material (aneurysm clip, mechanical artificial valve, nerve stimulator, insulin pump, intraocular metal, etc.)
5. Those who are judged by the principal investigator to be inappropriate as research subjects

Healthy people
1. Those who have significant hearing impairment and cannot communicate
2. Those who have a cardiac pacemaker
3. Those who are holding a body-metal that cannot be confirmed to be non-magnetic (aneurysm clip, mechanical artificial valve, nerve stimulator, insulin pump, intraocular metal, etc.)
4. Those who are judged by the principal investigator to be inappropriate as research subjects

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of activity changes in EEG between brain stimulation intervention and sham stimulation intervention (power spectrum analysis and coherence analysis)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath